1. Sphingosine-1-Phosphate Receptor-2 Antagonists: Therapeutic Potential and Potential Risks
    Kira V. Blankenbach et al, 2016, Front. Pharmacol. CrossRef
  2. Regulation of adipogenesis by ceramide 1-phosphate
    Marta Ordoñez et al, 2018, Experimental Cell Research CrossRef
  3. Obesity and dyslipidemia
    Jelena Vekic et al, 2018, Metabolism CrossRef
  4. Ceramide and sphingosine 1-phosphate in adipose dysfunction
    Zijian Fang et al, 2019, Progress in Lipid Research CrossRef
  5. Ceramide and sphingosine 1-phosphate in adipose dysfunction
    Zijian Fang et al, 2019, Progress in Lipid Research CrossRef
  6. The effect of the bioactive sphingolipids S1P and C1P on multipotent stromal cells – new opportunities in regenerative medicine
    Krzysztof Marycz et al, 2015 CrossRef
  7. A review on possible therapeutic targets to contain obesity: The role of phytochemicals
    Meriga Balaji et al, 2016, Obesity Research & Clinical Practice CrossRef
  8. Implication of phosphatidylethanolamine N-methyltransferase in adipocyte differentiation
    Natalia Presa et al, 2020, Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease CrossRef
  9. Effects of Sphingosine-1-Phosphate on Cell Viability, Differentiation, and Gene Expression of Adipocytes
    Xiyuan Wu et al, 2020, IJMS CrossRef
  10. Novel insights into the pathological mechanisms of metabolic related dyslipidemia
    Xin Su et al, 2021, Mol Biol Rep CrossRef
  11. Adipose Tissue Immunometabolism and Apoptotic Cell Clearance
    Tamás Röszer, 2021, Cells CrossRef
  12. S1P/S1PR3 signalling axis protects against obesity-induced metabolic dysfunction
    Sagarika Chakrabarty et al, 2022, Adipocyte CrossRef